FMP
SeaStar Medical Holding Corporation
ICU
NASDAQ
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.
1.39 USD
0.04 (2.88%)
Historical Prices
From:
To:
About
ceo
Mr. Eric Schlorff
sector
Healthcare
industry
Biotechnology
exchange
NASDAQ
Description
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and ...
CIK
0001831868
ISIN
US81256L1044
CUSIP
81256L104
Address
3513 Brighton Boulevard
Phone
844 427 8100
Country
US
Employee
19
IPO Date
Mar 18, 2021
Financial Statement
Earnings
ICU Financial Summary
CIK
0001831868
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
81256L104
ISIN
US81256L1044
Country
US
Price
1.39
Beta
-0.9
Volume Avg.
415.69k
Market Cap
12.12M
Shares
-
52-Week
1.21-20
DCF
0.98
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.21
P/B
-
Website
https://www.seastarmedical.com
Upgrades and Downgrades
We are unable to load the data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest ICU News
Tony Dante
7 days ago
SeaStar Medical Holding Corporation's Financial Performance ...
SeaStar Medical Holding Corporation, trading as NASDAQ:ICU, focuses on developing innovative treatments for critically ill patients. The company recently reported its financial results for the fourth quarter and full year of 2024. Despite making significant strides, ICU's earnings per share (EPS) of -$0.898 fell slightly below the estimated EPS of -$0.89. Additionally, the company's actual revenue of $67,000 was significantly lower than the estimated $150,000. In 2024, SeaStar Medical achieved ...
Gordon Thompson
Nov 13, 2024
ICU Medical Inc. (NASDAQ: ICUI) Showcases Strong Financial P...
ICU Medical Inc. (NASDAQ: ICUI) is a key player in the medical products industry, known for its innovative infusion therapy, oncology, and critical care products. The company competes with other medical device manufacturers, striving to deliver high-quality solutions to healthcare providers. On November 12, 2024, ICUI reported its third-quarter earnings, showcasing strong financial performance. ICUI reported earnings per share (EPS) of $1.59, surpassing the estimated $1.25. This represents a 27...
GlobeNewsWire
Jun 6, 2024
SeaStar Medical to Present at the Virtual Emerging Growth Co...
DENVER, June 06, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that Eric Schlorff, CEO, will hold a fireside chat at the Virtual Emerging Growth Conference on Wednesday, June 12 at 12:35 p.m. Eastern time (9:35 a.m. Pacific time).
GlobeNewsWire
Apr 11, 2024
SeaStar Medical to Present at the Noble Capital Markets' Eme...
DENVER, April 11, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that management will present at the Noble Capital Markets' Emerging Growth Virtual Healthcare Equity Conference on Thursday, April 18 at 9:30 a.m. Eastern time. The formal presentation will be followed by a hosted question-and-answer session.
GlobeNewsWire
Mar 11, 2024
SeaStar Medical-Sponsored Symposium Featuring Experts Discus...
March 13 webcast showcasing Quelimmune ™ scientific background and clinical data for pediatric AKI due to sepsis or a septic condition will be available on seastarmedical.com
InvestorPlace
Feb 22, 2024
Unleash Massive Returns With These 3 Top Penny Stocks
Despite a recent decline in the leading economic index, the U.S. economy is positioned for a positive future in 2024. Strong employment and robust stock levels contribute to the optimistic outlook.
Invezz
Feb 13, 2024
ICU stock price: Here's why SeaStar Medical shares have surg...
SeaStar Medical Holding (NASDAQ: ICU) stock price has done well this year even as the company continued diluting its shareholders. The stock is about to hit $1, meaning that it has surged by more than 177% from the lowest point in December and by 495% from its 2023 low.
PennyStocks
Oct 30, 2023
4 Penny Stocks To Watch Today With Big News, Time To Buy?
Trading penny stocks can be a risky endeavor, but having access to quality news and information can help mitigate some of that risk. As an investor or trader, it's critical to understand how news events can impact penny stocks and how to use news to your advantage when developing your trading strategy.
